Picture of HealthEquity logo

HQY HealthEquity News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyBalancedLarge CapHigh Flyer

HealthEquity's Q4 revenue rises, slightly beating estimates

Overview

U.S. HSA administrator's fiscal Q4 revenue rose 7%, slightly beating analyst expectations

Adjusted EBITDA for fiscal Q4 beat estimates, rising 23% year-over-year

Net income for fiscal Q4 missed analyst expectations

Outlook

HealthEquity sees fiscal 2027 revenue between $1.405 bln and $1.415 bln

Company expects fiscal 2027 net income of $239 mln to $246 mln

HealthEquity expects fiscal 2027 Adjusted EBITDA of $618 mln to $628 mln

Result Drivers

HSA GROWTH - Co said record new HSA sales and higher total HSA assets contributed to revenue growth

MARGIN EXPANSION - Adjusted EBITDA margin expanded more than 500 basis points to 40%, reflecting operating leverage, per CEO Scott Cutler

CUSTODIAL AND SERVICE REVENUE - Higher custodial and service revenue supported overall revenue increase

Company press release: ID:nGNX22SGVX

Key Details

MetricBeat/MissActualConsensus Estimate
Q4 RevenueSlight Beat*$334.59 mln$333.05 mln (14 Analysts)
Q4 EPS$0.58
Q4 Net IncomeMiss$49.74 mln$78.92 mln (11 Analysts)
Q4 Adjusted EBITDABeat$132.90 mln$130.55 mln (14 Analysts)
Q4 Pretax ProfitMiss$60.90 mln$106.12 mln (8 Analysts)
Q4 Gross Profit$228.15 mln
Q4 Operating Expenses$157.08 mln
*Applies to a deviation of less than 1%; not applicable for per-share numbers. Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 14 "strong buy" or "buy", 1 "hold" and 1 "sell" or "strong sell" The average consensus recommendation for the software peer group is "buy" Wall Street's median 12-month price target for Healthequity Inc is $123.50, about 57% above its March 16 closing price of $78.67 The stock recently traded at 17 times the next 12-month earnings vs. a P/E of 24 three months ago For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on HealthEquity

See all news